Class 4 Medicines Notification: Rabeprazole sodium 10mg and 20mg gastro-resistant tablets, EL(25)A/01
Bristol Laboratories Limited has informed the MHRA that the Patient Information Leaflet (PIL) in the batches in the table for Rabeprazole sodium 10mg and 20mg gastro-resistant tablets do not contain the most up to date safet…
View Original Alert
Important: This alert is aggregated automatically for information only.
Always refer to the original source and follow your practice's own clinical governance procedures.
About this source
Alerts and Recalls for Drugs and Medical Devices - General Practice
All alerts from this source
Get the weekly digest — all new alerts summarised and delivered to your NHS inbox every Monday.
View this week's digest